In conclusion, Deg-AZM downregulates the expression of Fn, Col1 and α-SMA in lung tissues, thereby reducing extracellular matrix deposition and bleomycin-induced lung fibrosis in mice. Here, FN1 is linked to pulmonary fibrosis.